// App-Quantinova.ai

EP450 : ALICE MAINTAINS HIGH CLINICAL RESPONSE RATES SUPPORTING THE EFFICACY OF IADADEMSTAT COMBINATION WITH AZACITIDINE IN AML MANAGEMENT

Researchers

Presenter

  • Olga Salamero

Principal Investigators

  • Tim Somervaille

  • Antonieta Molero

  • Evelyn Acua

  • Jose Antonio Perez-Simon

  • Ana Perez

  • Isabel Cano

  • Rebeca Rodriguez-Veira

  • Sonia Gutierrez

  • Carlos Buesa

  • Francesc Bosch

  • Pau Montesinos

Medical Centers

  • Oryzon Genomics, S.A., Cornella De Llobregat, Spain

  • Hospital Virgen del Rocio, Sevilla, Spain

  • Hospital Universitario La Fe de Valencia, Valencia, Spain

  • Vall d'Hebron University Hospital, Barcelona, Spain

  • Cancer Research UK Manchester Institute, University of Manchester, Manchester, United Kingdom.

Locations

  • Spain

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • Transthyretin

Drug/Treatment

  • Vidaza

  • Hydroxyurea

  • Iadademstat

Outcome

  • N/A

Study Design

  • Pharmacokinetics

  • Pharmacodynamics

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved